MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the sale of
product line
$309K
Net cash provided by
investing activities
$190K
Canceled cashflow
$119K
Net decrease in cash
and cash...
-$11,304K
Canceled cashflow
$190K
Accounts payable
$1,593K
Inventory excess and
obsolescence charge
$935K
Stock-based compensation
expense
$816K
Accounts receivable, net
-$593K
Noncash interest
expense
$238K
Prepaid expenses and
other current and...
-$231K
Depreciation expense
$169K
Amortization of intangible
assets
$95K
Income tax expense
$60K
Foreign currency
transaction loss
-$32K
Loss on disposal of
fixed assets
-$18K
Proceeds from issuance of
common stock under the...
$27K
Vesting of restricted
stock units
$1K
Purchase of property and
equipment
$119K
Net cash used in
operating activities
-$11,170K
Net cash used in
financing activities
-$298K
Canceled cashflow
$4,780K
Canceled cashflow
$28K
Effect of exchange rate
on cash and cash...
-$26K
Net loss
-$12,273K
Payment of accrued
offering costs
$247K
Payment of withholding
taxes related to...
$79K
Inventory
$2,158K
Accrued expenses and
other current and...
-$1,498K
Net changes in
operating lease rou assets...
$21K
Back
Back
Cash Flow
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)
source: myfinsight.com